297 related articles for article (PubMed ID: 14516825)
1. Ocular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic central serous chorioretinopathy.
Canakis C; Livir-Rallatos C; Panayiotis Z; Livir-Rallatos G; Persidis E; Conway MD; Peyman GA
Am J Ophthalmol; 2003 Oct; 136(4):750-2. PubMed ID: 14516825
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy.
Ober MD; Yannuzzi LA; Do DV; Spaide RF; Bressler NM; Jampol LM; Angelilli A; Eandi CM; Lyon AT
Ophthalmology; 2005 Dec; 112(12):2088-94. PubMed ID: 16325707
[TBL] [Abstract][Full Text] [Related]
3. Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy.
Kim SW; Oh J; Oh IK; Huh K
Ophthalmic Surg Lasers Imaging; 2009; 40(3):300-3. PubMed ID: 19485297
[TBL] [Abstract][Full Text] [Related]
4. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy.
Shinojima A; Kawamura A; Mori R; Fujita K; Yuzawa M
Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105
[TBL] [Abstract][Full Text] [Related]
5. [Photodynamic therapy in retinal pigment epithelium detachment associated with long term central serous chorioretinopathy].
Borque E; Ruiz O; Torrón C; Ferrer E; Alías E
Arch Soc Esp Oftalmol; 2008 Sep; 83(9):545-8. PubMed ID: 18803127
[TBL] [Abstract][Full Text] [Related]
6. [Photodynamic therapy for chronic central serous chorioretinopathy and diffuse retinal epitheliopathy].
Cornut PL; Quaranta-El Maftouhi M; Mauget-Faÿsse M
J Fr Ophtalmol; 2012 Feb; 35(2):82-7. PubMed ID: 21889817
[TBL] [Abstract][Full Text] [Related]
7. PHOTODYNAMIC THERAPY FOR SYMPTOMATIC SUBFOVEAL RETINAL PIGMENT EPITHELIAL DETACHMENT IN CENTRAL SEROUS CHORIORETINOPATHY: Outcomes and Prognostic Factors.
Hwang S; Kang SW; Kim SJ; Jang JW; Kim KT
Retina; 2019 Jun; 39(6):1117-1124. PubMed ID: 29517581
[TBL] [Abstract][Full Text] [Related]
8. Isolated pigment epithelium detachment: evidence for relation to central serous chorioretinopathy and effect of photodynamic therapy.
Arif F; Pryds A; Larsen M
Acta Ophthalmol; 2018 Dec; 96(8):821-827. PubMed ID: 30246489
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy for chronic central serous chorioretinopathy.
Cardillo Piccolino F; Eandi CM; Ventre L; Rigault de la Longrais RC; Grignolo FM
Retina; 2003 Dec; 23(6):752-63. PubMed ID: 14707823
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy in chronic central serous chorioretinopathy.
Battaglia Parodi M; Da Pozzo S; Ravalico G
Retina; 2003 Apr; 23(2):235-7. PubMed ID: 12707605
[No Abstract] [Full Text] [Related]
11. [Diffuse retinal epitheliopathy and central serous chorioretinopathy].
Cohen D; Gaudric A; Coscas G; Quentel G; Binaghi M
J Fr Ophtalmol; 1983; 6(4):339-49. PubMed ID: 6886302
[TBL] [Abstract][Full Text] [Related]
12. Unfavorable effect of photodynamic therapy for late subretinal neovascularization with chorioretinal anastomoses associated with idiopathic multiple serous detachments of the retinal pigment epithelium.
Fossarello M; Peiretti E; Zucca I; Serra A
Eur J Ophthalmol; 2004; 14(6):568-71. PubMed ID: 15638110
[TBL] [Abstract][Full Text] [Related]
13. Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization.
Gelisken F; Inhoffen W; Partsch M; Schneider U; Kreissig I
Am J Ophthalmol; 2001 Apr; 131(4):518-20. PubMed ID: 11292425
[TBL] [Abstract][Full Text] [Related]
14. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
Matušková V; Vysloužilová D; Uher M
Semin Ophthalmol; 2018; 33(5):690-699. PubMed ID: 29252091
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.
Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913
[TBL] [Abstract][Full Text] [Related]
16. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study.
Yannuzzi LA; Slakter JS; Gross NE; Spaide RF; Costa D; Huang SJ; Klancnik JM; Aizman A
Retina; 2003 Jun; 23(3):288-98. PubMed ID: 12824827
[TBL] [Abstract][Full Text] [Related]
17. Retinal capillary hemangioma treated with verteporfin photodynamic therapy.
Atebara NH
Am J Ophthalmol; 2002 Nov; 134(5):788-90. PubMed ID: 12429270
[TBL] [Abstract][Full Text] [Related]
18. Considering photodynamic therapy as a therapeutic modality in selected cases of dome-shaped macula complicated by foveal serous retinal detachment.
Arapi I; Neri P; Mariotti C; Gesuita R; Pirani V; Freddo F; Lutaj P; Giovannini A
Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):217-23. PubMed ID: 25707047
[TBL] [Abstract][Full Text] [Related]
19. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.
Chan WM; Lai TY; Lai RY; Liu DT; Lam DS
Ophthalmology; 2008 Oct; 115(10):1756-65. PubMed ID: 18538401
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy with verteporfin for retinal angiomatous proliferation.
Boscia F; Parodi MB; Furino C; Reibaldi M; Sborgia C
Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1224-32. PubMed ID: 16525824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
